Compass Therapeutics (NASDAQ: CMPX) revenue
Compass Therapeutics reported revenue of $0.0m for fiscal 2025, 100.0% less than in fiscal 2024 ($0.9m).
Compass Therapeutics's best year of the last 3 was fiscal 2024.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2025 | $0.0m | −100.0% | −$72.8m | — |
| 2024 | $0.9m | — | −$56.6m | −6,661.8% |
| 2023 | $0.0m | — | −$50.4m | — |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Compass Therapeutics revenue compared with its sector
By revenue for its latest fiscal year, Compass Therapeutics ranks 406th of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; Compass Therapeutics, −100.0%.
| Rank | Company | Revenue | Revenue growth |
|---|---|---|---|
| 404th | Artiva Biotherapeutics | $0.0m | −100.0% |
| 405th | Capricor Therapeutics | $0.0m | −100.0% |
| 406th | Compass Therapeutics | $0.0m | −100.0% |
| 407th | Denali Therapeutics | $0.0m | — |
| 408th | Design Therapeutics | $0.0m | — |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the revenue of Compass Therapeutics
- How much revenue did Compass Therapeutics make in fiscal 2025?
- Compass Therapeutics reported revenue of $0.0m for fiscal 2025, compared with $0.9m in fiscal 2024.
- What was the best year for revenue at Compass Therapeutics?
- Of its last 3 fiscal years, fiscal 2024, with $0.9m.
- Where does Compass Therapeutics rank in its sector by revenue?
- It ranks 406th of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
- Where do the figures for Compass Therapeutics come from?
- From the annual report (Form 10-K) that Compass Therapeutics files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Compass Therapeutics files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023. More on Compass Therapeutics: the Compass Therapeutics page · annual accounts · net income · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.